+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Addisons Disease Drug"

From
From
Global Addison's Disease Therapeutics Market 2023-2027 - Product Thumbnail Image

Global Addison's Disease Therapeutics Market 2023-2027

  • Report
  • November 2022
  • 120 Pages
  • Global
From
From
From
  • 6 Results (Page 1 of 1)
Loading Indicator

Addisons Disease Drug market is a segment of the Endocrine and Metabolic Disorders Drugs market. It is a specialized market that focuses on drugs used to treat Addisons Disease, a rare disorder of the adrenal glands. These drugs are used to replace the hormones that the adrenal glands are not producing, and to help regulate the body's metabolism. The drugs are typically administered orally or through injections, and may be used in combination with other treatments. The Addisons Disease Drug market is a small but growing market, with a focus on providing effective treatments for this rare disorder. Companies in the market are researching and developing new drugs to improve the quality of life for those suffering from Addisons Disease. Some companies in the Addisons Disease Drug market include Novartis, Pfizer, Merck, and AbbVie. Show Less Read more